Trial 0S-14-8


Randomized, Placebo-Controlled, Double-Blind Phase II/III Trial of Oral Isoquercetin to Prevent Venous Thromboembolic Events in Cancer Patients

Type: Prevention
Phase: Phase II/III
Status: Not Open (Closed)
Treatments: Other
Randomized: Not Asked
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Howard Liebman, M.D.
Other Trial Staff:  Christine Duran, Coordinator, Teresa Olea, R.N., Anastasia Martynova, D.M., Anastasia Martynova, D.M., Donna Fernando, R.N., Ibrahim Meena, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.